BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 19653953)

  • 1. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy].
    Sopracordevole F; Cigolot F; Lucia E; Marchesoni D
    Minerva Ginecol; 2009 Apr; 61(2):81-7. PubMed ID: 19255555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quadrivalent human papillomavirus vaccine.
    Barr E; Tamms G
    Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus, genital warts, and vaccines.
    Hsueh PR
    J Microbiol Immunol Infect; 2009 Apr; 42(2):101-6. PubMed ID: 19597640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the power of prevention: human papillomavirus vaccines.
    Mayeaux EJ
    Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus and genital cancer.
    Rapose A
    Indian J Dermatol Venereol Leprol; 2009; 75(3):236-43; quiz 243-4. PubMed ID: 19439875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women.
    Sperber NR; Brewer NT; Smith JS
    Cancer Causes Control; 2008 Feb; 19(1):115-8. PubMed ID: 17952620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M
    Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV vaccination catch up program - utilisation by young Australian women.
    Weisberg E; Bateson D; McCaffery K; Skinner SR
    Aust Fam Physician; 2009; 38(1-2):72-6. PubMed ID: 19283241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
    Garland SM; Hernandez-Avila M; Wheeler CM; Perez G; Harper DM; Leodolter S; Tang GW; Ferris DG; Steben M; Bryan J; Taddeo FJ; Railkar R; Esser MT; Sings HL; Nelson M; Boslego J; Sattler C; Barr E; Koutsky LA;
    N Engl J Med; 2007 May; 356(19):1928-43. PubMed ID: 17494926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
    Thomas TL
    Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
    Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
    Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV vaccine and its recommendations, 2007.
    Zimmerman RK
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S1-5, C1. PubMed ID: 17270106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and natural history of genital human papillomavirus infection.
    Weaver BA
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statement on human papillomavirus vaccine. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Feb; 33(ACS-2):1-31. PubMed ID: 17520773
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges to accepting a human papilloma virus (HPV) vaccine: a qualitative study of Australian women.
    Rosenthal D; Dyson S; Pitts M; Garland S
    Women Health; 2007; 45(2):59-73. PubMed ID: 18019286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.
    Kjaer SK; Tran TN; Sparen P; Tryggvadottir L; Munk C; Dasbach E; Liaw KL; Nygård J; Nygård M
    J Infect Dis; 2007 Nov; 196(10):1447-54. PubMed ID: 18008222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic HPV vaccines: new interventions for cancer control.
    Barr E; Sings HL
    Vaccine; 2008 Nov; 26(49):6244-57. PubMed ID: 18694795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.